Skip to main content
Top
Published in: Endocrine 3/2016

01-12-2016 | Letter to the Editor

Physical exercise and dementia in patients with type 2 diabetes mellitus

Author: Tomoyuki Kawada

Published in: Endocrine | Issue 3/2016

Login to get access

Excerpt

I read with interest the recent review by Bertram et al. [1], in Endocrine. The authors overviewed the epidemiological association between type 2 diabetes mellitus (T2DM) and dementia, and speculated the biological mechanism on the association with special reference to chronic inflammation, oxidative stress, dyslipidemia, reduced β-amyloid clearance, and hormonal change. Thereafter, the authors intensively summarized the effect of physical exercise on dementia prevention in patients with T2DM. I fundamentally accept their recommendation of physical exercise, although biological evidence seems not enough to confirm the causal association. I have some concerns on their summary. …
Literature
1.
go back to reference S. Bertram, K. Brixius, C. Brinkmann, Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients. Endocrine 53, 350–363 (2016)CrossRefPubMed S. Bertram, K. Brixius, C. Brinkmann, Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients. Endocrine 53, 350–363 (2016)CrossRefPubMed
2.
go back to reference L.D. Baker, L.L. Frank, K. Foster-Schubert, P.S. Green, C.W. Wilkinson, A. McTiernan, B.A. Cholerton, S.R. Plymate, M.A. Fishel, G.S. Watson, G.E. Duncan, P.D. Mehta, S. Craft, Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer’s disease. J. Alzheimers Dis. 22, 569–579 (2010)PubMedPubMedCentral L.D. Baker, L.L. Frank, K. Foster-Schubert, P.S. Green, C.W. Wilkinson, A. McTiernan, B.A. Cholerton, S.R. Plymate, M.A. Fishel, G.S. Watson, G.E. Duncan, P.D. Mehta, S. Craft, Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer’s disease. J. Alzheimers Dis. 22, 569–579 (2010)PubMedPubMedCentral
3.
go back to reference E.H. Mizrahi, A. Waitzman, T. Blumstein, M. Arad, A. Adunsky, Diabetes mellitus predicts cognitive impairment in patients with ischemic stroke. Am. J. Alzheimers Dis. Other Demen. 25, 362–366 (2010)CrossRefPubMed E.H. Mizrahi, A. Waitzman, T. Blumstein, M. Arad, A. Adunsky, Diabetes mellitus predicts cognitive impairment in patients with ischemic stroke. Am. J. Alzheimers Dis. Other Demen. 25, 362–366 (2010)CrossRefPubMed
4.
go back to reference J.S. Roriz-Filho, T.M. Sá-Roriz, I. Rosset, A.L. Camozzato, A.C. Santos, M.L. Chaves, J.C. Moriguti, M. Roriz-Cruz, (Pre)diabetes, brain aging, and cognition. Biochim. Biophys. Acta. 1792, 432–443 (2009)CrossRef J.S. Roriz-Filho, T.M. Sá-Roriz, I. Rosset, A.L. Camozzato, A.C. Santos, M.L. Chaves, J.C. Moriguti, M. Roriz-Cruz, (Pre)diabetes, brain aging, and cognition. Biochim. Biophys. Acta. 1792, 432–443 (2009)CrossRef
5.
go back to reference M. Baumgart, H.M. Snyder, M.C. Carrillo, S. Fazio, H. Kim, H. Johns, Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 11, 718–726 (2015)CrossRefPubMed M. Baumgart, H.M. Snyder, M.C. Carrillo, S. Fazio, H. Kim, H. Johns, Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 11, 718–726 (2015)CrossRefPubMed
Metadata
Title
Physical exercise and dementia in patients with type 2 diabetes mellitus
Author
Tomoyuki Kawada
Publication date
01-12-2016
Publisher
Springer US
Published in
Endocrine / Issue 3/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1100-9

Other articles of this Issue 3/2016

Endocrine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine